XML 67 R53.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies Summary of Significant Accounting Policies - Revision of Previously Issued Financial Statements (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Revision of Previously Issued Financial Statements [Line Items]                        
Deferred income tax assets $ 42.9       $ 34.4       $ 42.9 $ 34.4    
Total assets [1] 5,175.0       4,864.5       5,175.0 4,864.5    
Change in fair value                 (91.0) (67.0) $ (10.9)  
Provision for income tax expense 29.4 $ 30.2 $ 29.3 $ 30.0 34.4 $ 43.1 $ 28.6 $ 39.7 118.9 145.8 163.9  
Capital in excess of par value 2,588.7       2,747.4       2,588.7 2,747.4    
Accumulated deficit (885.2)       (1,176.2)       (885.2) (1,176.2)    
Encompass Health shareholders’ equity 1,276.7       1,152.5       1,276.7 1,152.5    
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1,557.0       1,395.4       1,557.0 1,395.4 910.6 $ 765.4
Liabilities and Equity 5,175.0       4,864.5       5,175.0 4,864.5    
Income from continuing operations 46.2 109.4 113.0 105.7 101.5 85.2 79.2 84.7 374.3 350.6 318.1  
Net income 47.7 109.3 113.2 105.2 101.3 85.1 79.4 84.4 375.4 350.2 318.1  
Net income attributable to Encompass Health $ 28.1 $ 88.6 $ 91.8 $ 83.8 $ 75.4 $ 65.9 $ 63.0 $ 66.8 292.3 271.1 247.6  
Comprehensive income                 375.4 350.1 318.1  
Comprehensive income attributable to Encompass Health                 $ 292.3 $ 271.0 $ 247.6  
Earnings Per Share, Basic $ 0.29 $ 0.90 $ 0.93 $ 0.85 $ 0.77 $ 0.67 $ 0.70 $ 0.75 $ 2.98 $ 2.88 $ 2.77  
Earnings Per Share, Diluted $ 0.28 $ 0.89 $ 0.92 $ 0.84 $ 0.76 $ 0.67 $ 0.70 $ 0.70 $ 2.93 $ 2.84 $ 2.59  
Deferred tax expense                 $ (9.1) $ 60.8 $ 132.9  
Accumulated Deficit [Member]                        
Revision of Previously Issued Financial Statements [Line Items]                        
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ (885.2)       $ (1,176.2)       (885.2) (1,176.2) (1,448.4) (1,696.0)
Capital in Excess of Par Value [Member]                        
Revision of Previously Issued Financial Statements [Line Items]                        
Change in fair value                 (91.0) (67.0) (10.9)  
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ 2,588.7       2,747.4       $ 2,588.7 2,747.4 2,781.0 2,821.0
As Reported [Member]                        
Revision of Previously Issued Financial Statements [Line Items]                        
Deferred income tax assets         63.6         63.6    
Total assets [1]         4,893.7         4,893.7    
Change in fair value                   (41.0) (6.7)  
Provision for income tax expense         49.2         160.6    
Capital in excess of par value         2,791.4         2,791.4    
Accumulated deficit         (1,191.0)         (1,191.0)    
Encompass Health shareholders’ equity         1,181.7         1,181.7    
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest         1,424.6         1,424.6 928.7 779.3
Liabilities and Equity         4,893.7         4,893.7    
Income from continuing operations         86.7         335.8    
Net income         86.5         335.4    
Net income attributable to Encompass Health         $ 60.6         256.3    
Comprehensive income                   335.3    
Comprehensive income attributable to Encompass Health                   $ 256.2    
Earnings Per Share, Basic         $ 0.62         $ 2.73    
Earnings Per Share, Diluted         $ 0.61         $ 2.69    
Deferred tax expense                   $ 75.6    
As Reported [Member] | Accumulated Deficit [Member]                        
Revision of Previously Issued Financial Statements [Line Items]                        
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest         $ (1,191.0)         (1,191.0)    
As Reported [Member] | Capital in Excess of Par Value [Member]                        
Revision of Previously Issued Financial Statements [Line Items]                        
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest         2,791.4         2,791.4 2,799.1 2,834.9
Adjustment [Member]                        
Revision of Previously Issued Financial Statements [Line Items]                        
Deferred income tax assets         (29.2)         (29.2)    
Total assets [1]         (29.2)         (29.2)    
Change in fair value                   (26.0) (4.2)  
Provision for income tax expense         (14.8)         (14.8)    
Capital in excess of par value         (44.0)         (44.0)    
Accumulated deficit         14.8         14.8    
Encompass Health shareholders’ equity         (29.2)         (29.2)    
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest         (29.2)         (29.2) (18.1) (13.9)
Liabilities and Equity         (29.2)         (29.2)    
Income from continuing operations         14.8         14.8    
Net income         14.8         14.8    
Net income attributable to Encompass Health         $ 14.8         14.8    
Comprehensive income                   14.8    
Comprehensive income attributable to Encompass Health                   $ 14.8    
Earnings Per Share, Basic         $ 0.15         $ 0.15    
Earnings Per Share, Diluted         $ 0.15         $ 0.15    
Deferred tax expense                   $ (14.8)    
Adjustment [Member] | Accumulated Deficit [Member]                        
Revision of Previously Issued Financial Statements [Line Items]                        
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest         $ 14.8         14.8    
Adjustment [Member] | Capital in Excess of Par Value [Member]                        
Revision of Previously Issued Financial Statements [Line Items]                        
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest         $ (44.0)         $ (44.0) $ (18.1) $ (13.9)
[1] Our consolidated assets as of December 31, 2018 and December 31, 2017 include total assets of variable interest entities of $197.5 million and $264.1 million, respectively, which cannot be used by us to settle the obligations of other entities. Our consolidated liabilities as of December 31, 2018 and December 31, 2017 include total liabilities of the variable interest entities of $50.8 million and $52.5 million, respectively. See Note 3, Variable Interest Entities.